HHealthcare Read More Eli Lilly (LLY) earnings Q4 2025February 4, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 30, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…
HHealthcare Read More Next steps for Eli Lilly, Novo Nordisk, PfizerJanuary 23, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
HHealthcare Read More Johnson & Johnson (JNJ) Q4 earningsJanuary 21, 2026 Johnson & Johnson said on Thursday that it has reached an agreement with the U.S. President administration to…
HHealthcare Read More Another alliance of health care and AI signals why pharma stocks could be backJanuary 20, 2026 Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
HHealthcare Read More First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.January 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
MMedication Read More Novo Nordisk beyond weight loss has investors wary, scientists hopefulJanuary 1, 2026 Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…